Russell E. Lewis, PharmD

University of Bologna, Italy

Disclosure(s): Air: Advisor/Consultant; Cidara: Advisor/Consultant; F2G: Advisor/Consultant; Gilead: Advisor/Consultant; Merck & Co, Inc: Grant/Research Support; Synexis: Advisor/Consultant

Poster(s):

• 2114 - Invasive fusariosis in the era of mold active azoles and molecular targeted chemotherapy: Increasing incidence and lack of improved outcomes
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET